JPH07252289A - Production of glycoside compound - Google Patents
Production of glycoside compoundInfo
- Publication number
- JPH07252289A JPH07252289A JP6067706A JP6770694A JPH07252289A JP H07252289 A JPH07252289 A JP H07252289A JP 6067706 A JP6067706 A JP 6067706A JP 6770694 A JP6770694 A JP 6770694A JP H07252289 A JPH07252289 A JP H07252289A
- Authority
- JP
- Japan
- Prior art keywords
- derivatives
- thioglycoside
- perchlorate
- alcohols
- glycoside compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 glycoside compound Chemical class 0.000 title claims abstract description 30
- 229930182470 glycoside Natural products 0.000 title claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 229930182475 S-glycoside Natural products 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 150000003569 thioglycosides Chemical class 0.000 claims abstract description 12
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims abstract description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- 239000011630 iodine Substances 0.000 claims abstract description 8
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 8
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims abstract description 8
- 150000003862 amino acid derivatives Chemical class 0.000 claims abstract description 6
- 150000002314 glycerols Chemical class 0.000 claims abstract description 6
- 235000000346 sugar Nutrition 0.000 claims description 19
- FUCBQMFTYFQCOB-UHFFFAOYSA-N trityl perchlorate Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(OCl(=O)(=O)=O)C1=CC=CC=C1 FUCBQMFTYFQCOB-UHFFFAOYSA-N 0.000 claims description 5
- 150000001719 carbohydrate derivatives Chemical class 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 150000008163 sugars Chemical class 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000012190 activator Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 4
- QYIXCDOBOSTCEI-UJOPKFNNSA-N (3s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-ol Chemical compound C1CC2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 QYIXCDOBOSTCEI-UJOPKFNNSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- GKHCBYYBLTXYEV-LBELIVKGSA-N (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-phenylmethoxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OCC1=CC=CC=C1 GKHCBYYBLTXYEV-LBELIVKGSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000000348 glycosyl donor Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- IKCMSYGNAFDJNX-CAIHAHRASA-N (2r,3r,4s,5r)-3,4,5-tris(phenylmethoxy)-2-(phenylmethoxymethyl)-6-phenylsulfanyloxane Chemical compound C([C@@H]1[C@H]([C@H](OCC=2C=CC=CC=2)[C@@H](OCC=2C=CC=CC=2)C(SC=2C=CC=CC=2)O1)OCC=1C=CC=CC=1)OCC1=CC=CC=C1 IKCMSYGNAFDJNX-CAIHAHRASA-N 0.000 description 1
- ZNKMCQRFDSVZAX-DFLSAPQXSA-N (2r,3r,4s,5r,6s)-6-methoxy-4,5-bis(phenylmethoxy)-2-(phenylmethoxymethyl)oxan-3-ol Chemical compound C([C@H]1O[C@@H]([C@@H]([C@@H](OCC=2C=CC=CC=2)[C@@H]1O)OCC=1C=CC=CC=1)OC)OCC1=CC=CC=C1 ZNKMCQRFDSVZAX-DFLSAPQXSA-N 0.000 description 1
- UILNWDYGLDOQAD-BMURFIBDSA-N (3R,4S,5R,6R)-2-methylsulfanyl-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxane Chemical compound CSC1O[C@H](COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1OCc1ccccc1 UILNWDYGLDOQAD-BMURFIBDSA-N 0.000 description 1
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- MQWCXKGKQLNYQG-UHFFFAOYSA-N 4-methylcyclohexan-1-ol Chemical compound CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- RBWNDBNSJFCLBZ-UHFFFAOYSA-N 7-methyl-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidine-4-thione Chemical compound N1=CNC(=S)C2=C1SC1=C2CCC(C)C1 RBWNDBNSJFCLBZ-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- POORJMIIHXHXAV-SOYHJAILSA-N [(3ar,5r,5as,8as,8br)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydro-3ah-di[1,3]dioxolo[4,5-a:5',4'-d]pyran-5-yl]methanol Chemical compound O1[C@H](CO)[C@@H]2OC(C)(C)O[C@@H]2[C@H]2OC(C)(C)O[C@H]21 POORJMIIHXHXAV-SOYHJAILSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N aldehydo-N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 1
- 229910001486 lithium perchlorate Inorganic materials 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- IQSQTOWMVAKJTC-JAJWTYFOSA-N molport-027-945-912 Chemical compound O1[C@H]2OC[C@@H]1[C@@H]1OC(C)(C)O[C@@H]1[C@H]2O IQSQTOWMVAKJTC-JAJWTYFOSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Chemical class 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
【0001】[0001]
【発明の概要】本発明は新規なグリコシド系化合物の製
造方法に関する。詳しくはチオグリコシド誘導体と、脂
肪族アルコール、芳香族アルコール、ステロイドアルコ
ール、グリセロール誘導体、糖誘導体、アミノ酸誘導体
から選ばれるアルコールとを、ヨウ素と過塩素酸塩を共
存させ、反応させる事を特徴とするグリコシド系化合物
の製造方法に関する。SUMMARY OF THE INVENTION The present invention relates to a method for producing a novel glycoside compound. Specifically, it is characterized by reacting a thioglycoside derivative with an alcohol selected from aliphatic alcohols, aromatic alcohols, steroid alcohols, glycerol derivatives, sugar derivatives and amino acid derivatives in the presence of iodine and perchlorate. The present invention relates to a method for producing a glycoside compound.
【0002】[0002]
【産業上の利用分野】グリコシド系化合物は抗生物質、
制ガン剤等として医薬、農薬などの用途に注目をあびて
いるが、特に最近では細胞の接着や分化などと密接に関
わっている事が明らかにされ、新たな医薬としてその開
発が期待されている。[Industrial application] Glycoside compounds are antibiotics,
As an anti-cancer drug and the like, attention has been focused on the use of medicines, agricultural chemicals, etc., but recently it has been revealed that they are closely related to cell adhesion and differentiation, and their development is expected as a new medicine.
【0003】[0003]
【従来の技術】その合成には不安定な中間体を使用する
ため、工業的に優れた方法は限られている。古くから知
られている方法はハロゲノ糖とアルコールを反応させる
が、原料のハロゲノ糖の安定性が乏しいこと、高度に脱
水した反応条件が必要なこと等欠点が多く工業化は困難
である。BACKGROUND OF THE INVENTION Because of the use of unstable intermediates in their synthesis, industrially superior methods are limited. The method known for a long time is to react a halogeno sugar with an alcohol, but it is difficult to industrialize due to many drawbacks such as poor stability of the starting halogeno sugar and the need for highly dehydrated reaction conditions.
【0004】[0004]
【発明が解決しようとする課題】既に、こうした問題を
解決する方法としてチオグリコシド誘導体を用いるグリ
コシル化反応が知られている。しかし、活性化剤が高価
で、扱いにくい等の欠点があった。本発明者らは上記の
事情に鑑み鋭意研究した結果、新規なチオグリコシドの
活性化法、すなわち、本発明に到達した。The glycosylation reaction using a thioglycoside derivative is already known as a method for solving these problems. However, the activator is expensive and difficult to handle. As a result of intensive studies in view of the above circumstances, the present inventors have arrived at a novel thioglycoside activation method, that is, the present invention.
【0005】[0005]
【発明の要旨】すなわち、本発明の要旨は、チオグリコ
シドと、脂肪族アルコール、芳香族アルコール、ステロ
イドアルコール、グリセロール誘導体、糖誘導体、アミ
ノ酸誘導体から選ばれるアルコールとを、ヨウ素及び過
塩素酸塩を共存させ、反応させる事を特徴とするグリコ
シド系化合物の製造方法である。That is, the gist of the present invention is that thioglycoside and an alcohol selected from aliphatic alcohols, aromatic alcohols, steroid alcohols, glycerol derivatives, sugar derivatives, and amino acid derivatives, iodine and perchlorate are used. It is a method for producing a glycoside compound, which is characterized by allowing them to coexist and react.
【0006】[0006]
【課題を解決するための手段】以下、本発明を詳細に説
明する。The present invention will be described in detail below.
【0007】まず、本発明の原料の一つ、チオグリコシ
ドは周知の誘導体を用いることができる。用いる糖の環
状構造は5員環であっても6員環であってもよい。通常
アルドースを使用するが、ケトースも使用する事ができ
る。具体的にはこれらの糖として、エリスロース、スレ
オース等のテトラオース、リボース、アラビノース、キ
シロース等のペントース、グルコ−ス、マンノ−ス、ガ
ラクト−ス、アロース、タロース等のヘキソース、また
は2−デオキシグルコース、2−デオキシリボース等こ
れらの糖の一部がデオキシ化された糖あるいは2−アセ
トアミド−2−デオキシグルコ−ス等のアミノ糖、さら
には、ラクトース等のようにこれらの糖が相互にエーテ
ル結合したオリゴ糖や、シアル酸、グルクロン酸などを
挙げることができる。また、これらの糖にはD体、L体
が存在するが、そのいずれでも、また、混合物でも使用
できる。加えて、チオグリコシドにはメチルチオグリコ
シド、エチルチオグリコシド等のアルキルチオグリコシ
ドやフェニルチオグリコシド等の芳香族チオグリコシド
が知られているが、こうしたチオグリコシドの置換基に
よる制限もない。First, a well-known derivative can be used for thioglycoside, which is one of the raw materials of the present invention. The cyclic structure of the sugar used may be a 5-membered ring or a 6-membered ring. Usually aldose is used, but ketose can also be used. Specifically, as these sugars, erythrose, tetraose such as threose, ribose, arabinose, pentose such as xylose, glucose, mannose, galactose, allose, hexose such as talose, or 2-deoxyglucose. , 2-deoxyribose and other sugars in which some of these sugars are deoxygenated, amino sugars such as 2-acetamido-2-deoxyglucose, and further, these sugars are ether-bonded to each other, such as lactose. Examples thereof include oligosaccharides, sialic acid and glucuronic acid. Further, these sugars have D-form and L-form, but any of them or a mixture can be used. In addition, as thioglycoside, alkyl thioglycoside such as methyl thioglycoside and ethyl thioglycoside, and aromatic thioglycoside such as phenyl thioglycoside are known, but there is no limitation by the substituent of such thioglycoside.
【0008】これらの糖はアノマー位以外の水酸基を全
て保護して使用できる事は言うまでもないが、溶解性等
のため必要最小限保護した遊離の水酸基を有する誘導体
でも差し支えない。Needless to say, these sugars can be used with all hydroxyl groups other than the anomeric position protected, but derivatives having a free hydroxyl group protected to the minimum necessary for solubility etc. may be used.
【0009】水酸基の保護基としては従来周知のものを
使用できる。具体的には、アセチル、トリフルオロアセ
チル、トリクロルアセチル、ベンゾイル、p-ニトロベン
ゾイル基等のアシル基で保護する方法、アセトアルデヒ
ド、アセトンなどでアセタール化する方法、メチル、ベ
ンジル、トリフェニルメチル基等のアルキル基でエーテ
ル化する方法、t-ブチルジメチルシリル、t-ブチルジフ
ェニルシリル基等でシリル化する方法などを挙げること
ができる。As the protective group for the hydroxyl group, conventionally known ones can be used. Specifically, a method of protecting with an acyl group such as acetyl, trifluoroacetyl, trichloroacetyl, benzoyl, p-nitrobenzoyl group, a method of acetalizing with acetaldehyde, acetone, etc., a methyl, benzyl, triphenylmethyl group, etc. Examples thereof include a method of etherification with an alkyl group, a method of silylation with a t-butyldimethylsilyl group, a t-butyldiphenylsilyl group and the like.
【0010】反応させるアルコールとしては周知のアル
コールを使用できる。周知のアルコールとしては、脂肪
族アルコール、芳香族アルコール、ステロイドアルコー
ル、グリセロール誘導体、糖誘導体、アミノ酸誘導体な
どの水酸基を有する化合物を使用できる。Well-known alcohols can be used as the alcohol to be reacted. As the well-known alcohol, a compound having a hydroxyl group such as an aliphatic alcohol, an aromatic alcohol, a steroid alcohol, a glycerol derivative, a sugar derivative and an amino acid derivative can be used.
【0011】脂肪族アルコールとしては、メタノール、
エタノール、プロパノール、イソプロパノール、セチル
アルコール、ブタノール、エチレングリコール、プロピ
レングリコールなどを挙げる事ができる。勿論、シクロ
ヘキサノール、メチルシクロヘキサノール、メントール
等の環状脂肪族アルコールも使用できる。As the aliphatic alcohol, methanol,
Examples thereof include ethanol, propanol, isopropanol, cetyl alcohol, butanol, ethylene glycol and propylene glycol. Of course, cycloaliphatic alcohols such as cyclohexanol, methylcyclohexanol and menthol can also be used.
【0012】芳香族アルコールとしては、フェノール、
p-クロロフェノール、o-クロロフェノール、2,4-ジニト
ロフェノール、p-クレゾール、o-クレゾール、α-ナフ
トール、β-ナフトール、カテコール、レゾルシノー
ル、ハイドロキノン等を挙げる事ができる。As the aromatic alcohol, phenol,
Examples thereof include p-chlorophenol, o-chlorophenol, 2,4-dinitrophenol, p-cresol, o-cresol, α-naphthol, β-naphthol, catechol, resorcinol and hydroquinone.
【0013】ステロイドアルコールとしては、コレステ
ロール、コレスタノール、スチグマステロール、エスト
ロン、エストラジオール、テストステロン、アンドロス
テロン等が挙げられる。Examples of steroid alcohols include cholesterol, cholestanol, stigmasterol, estrone, estradiol, testosterone, androsterone and the like.
【0014】グリセロール誘導体としては、グリセリン
及びそのモノアシル体、ジアシル体を挙げる事ができ
る。ここで、アシル基としてはアセチル、ベンゾイル、
パルミチル、ステアリル、オレイル基等を挙げる事がで
き、ジアシル体では同一のアシル基であっても、異なる
アシル基であっても何等支障はない。これらの誘導体に
は立体異性体が存在するものがあるが、そのいずれであ
っても混合物であっても使用できる事は言うまでもな
い。加えて、一部の水酸基が他の官能基に変換された誘
導体をもこれらの範疇に含まれる。例えば、スフィンゴ
シン誘導体、セラミドなどを挙げる事ができる。Examples of glycerol derivatives include glycerin and its monoacyl and diacyl derivatives. Here, as the acyl group, acetyl, benzoyl,
Examples thereof include palmityl, stearyl, and oleyl groups, and in the diacyl form, the same or different acyl groups can be used without any problem. Some of these derivatives have stereoisomers, but it goes without saying that any of them or a mixture thereof can be used. In addition, a derivative in which some hydroxyl groups are converted into other functional groups is also included in these categories. For example, a sphingosine derivative, ceramide, etc. can be mentioned.
【0015】糖誘導体としては、周知の糖を使用でき
る。すなわち、前述した糖を使用できるが、必ずしも環
状である必要はなく、鎖状の糖誘導体をも使用できる。
糖には、数多くの水酸基があるが、反応に関与しない水
酸基は全て前述した方法により保護しておく方が望まし
いが、反応性などを考慮して、保護基の使用を必要最小
限にする事も可能である。Well-known sugars can be used as the sugar derivative. That is, although the above-mentioned sugars can be used, they need not necessarily be cyclic, and chain sugar derivatives can also be used.
Although sugar has many hydroxyl groups, it is desirable to protect all hydroxyl groups that do not participate in the reaction by the above-mentioned method, but in consideration of reactivity etc., the use of protecting groups should be minimized to the minimum necessary. Is also possible.
【0016】アミノ酸誘導体としては、セリン、スレオ
ニン、ヒドロキシプロリン、ヒドロキシリジン、チロシ
ンなどを挙げる事ができる。これらのアミノ酸には、D
体とL体が存在するが、そのいずれでも、また、混合物
であっても使用できる事は言うまでもない。また、種々
のアミノ酸から誘導したアミノアルコールやペプチドの
誘導体を使用できる。これらの使用に際して、アミノ基
やカルボキシル基あるいは他の官能基を常法によって保
護した誘導体を使用できる事は当然である。Examples of amino acid derivatives include serine, threonine, hydroxyproline, hydroxylysine and tyrosine. These amino acids include D
There are body and L body, but it goes without saying that any of them or a mixture can be used. Further, amino alcohols derived from various amino acids and peptide derivatives can be used. In using these, it is natural that a derivative in which an amino group, a carboxyl group or other functional group is protected by a conventional method can be used.
【0017】次に活性化剤について述べる。活性化剤と
しては、ヨウ素と過塩素酸塩を共存させて使用する。Next, the activator will be described. As the activator, iodine and perchlorate are used together.
【0018】過塩素酸塩としては、周知の塩を使用でき
る。具体的には、過塩素酸銀、過塩素酸リチウム、過塩
素酸トリチルなどを挙げる事ができる。とりわけ、過塩
素酸トリチルが有効である。Well-known salts can be used as perchlorates. Specific examples thereof include silver perchlorate, lithium perchlorate, and trityl perchlorate. Especially, trityl perchlorate is effective.
【0019】溶媒としては、アルコール系以外の溶媒を
使用できる。すなわち、ベンゼン、トルエン、クロロホ
ルム、ジクロルメタン、ジクロルエタン、四塩化炭素、
酢酸エチル、エーテル、テトラヒドロフラン、ジメチル
ホルムアミド、アセトニトリル、プロピオニトリル、ニ
トロメタン等を挙げる事ができる。As the solvent, a solvent other than alcohol can be used. That is, benzene, toluene, chloroform, dichloromethane, dichloroethane, carbon tetrachloride,
Examples thereof include ethyl acetate, ether, tetrahydrofuran, dimethylformamide, acetonitrile, propionitrile, nitromethane and the like.
【0020】反応温度としても特に制限はない。しか
し、通常、-80℃から溶媒の沸点の範囲である。また、
操作性等を考慮すると-10℃〜室温の範囲が好ましい。The reaction temperature is also not particularly limited. However, it is usually in the range of -80 ° C to the boiling point of the solvent. Also,
Considering operability and the like, the range of -10 ° C to room temperature is preferable.
【0021】用いるチオグリコシド誘導体とアルコール
及び活性化剤の当量関係にも特に大きな制限はない。例
えば、グリコシル供与体あるいはアルコールを過剰に使
用する事も可能であるが、両者を等量使用する事も可能
である。一方、活性化剤は、その種類にもよるが、通常
過塩素酸塩及びヨウ素をそれぞれ0.01〜数等量使用す
る。好ましくは過塩素酸塩0.1〜1.5当量、ヨウ素0.5〜
1.5当量の範囲である。The equivalent relationship between the thioglycoside derivative used, the alcohol and the activator is not particularly limited. For example, it is possible to use the glycosyl donor or alcohol in excess, but it is also possible to use both in equal amounts. On the other hand, the activator usually uses 0.01 to several equivalents of perchlorate and iodine, respectively, depending on its type. Preferably perchlorate 0.1-1.5 equivalents, iodine 0.5-
It is in the range of 1.5 equivalents.
【0022】反応時間は反応させる糖やアルコールの構
造によっても異なるが、通常数分から数十時間の範囲で
ある。Although the reaction time varies depending on the structures of sugar and alcohol to be reacted, it is usually in the range of several minutes to several tens hours.
【0023】[0023]
【発明の効果】本発明方法によるグリコシド系化合物の
製造方法は、グリコシル供与体が安定なチオグリコシド
誘導体を用い、比較的安価で、かつ扱い易い試薬を活性
化剤として使用する利点を有しており、その工業的価値
は大きい。INDUSTRIAL APPLICABILITY The method for producing a glycoside compound according to the present invention has the advantage of using a thioglycoside derivative having a stable glycosyl donor and using a relatively inexpensive and easy-to-use reagent as an activator. And its industrial value is great.
【0024】以下に実施例を挙げて本発明を更に具体的
に説明するが、本発明はその要旨を超えない限り、以下
の実施例により何等制限を受けるものではない。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to the following examples as long as the gist thereof is not exceeded.
【0025】[0025]
【実施例1】メチル 2,3,4,6−テトラ−O−ベ
ンジル−1−チオ−D−グルコピラノシド49.9mg(0.09m
mol)と3β−コレスタノール33.4mg(0.09mmol)とを20ml
ナスフラスコに入れ、トルエン2mlで溶解させた後、モ
レキュラーシーブス4A約150mg加え、次に、過塩素酸
トリチル30.0mg(0.09mmol)を加えた。これに0.1Mヨウ
素/トルエン溶液0.87mlをシリンジで滴下し、一晩攪拌
した。5%チオ硫酸ナトリウム水溶液で反応を停止させ、
水と酢酸エチルを加え、分液した。常法により処理し、
シリカゲル薄層クロマトグラフィーで精製したところ、
対応する3β−コレスタニルグルコピラノシドが56.3mg
(71%)得られた。Example 1 Methyl 2,3,4,6-tetra-O-benzyl-1-thio-D-glucopyranoside 49.9 mg (0.09 m
mol) and 3β-cholestanol 33.4 mg (0.09 mmol) in 20 ml
The mixture was placed in an eggplant-shaped flask and dissolved with 2 ml of toluene, then about 150 mg of molecular sieves 4A was added, and then 30.0 mg (0.09 mmol) of trityl perchlorate was added. 0.87 ml of 0.1 M iodine / toluene solution was added dropwise thereto by a syringe, and the mixture was stirred overnight. Stop the reaction with a 5% aqueous sodium thiosulfate solution,
Water and ethyl acetate were added and the layers were separated. It is processed by a conventional method,
When purified by silica gel thin layer chromatography,
56.3 mg of the corresponding 3β-cholestanyl glucopyranoside
(71%) was obtained.
【0026】[0026]
【実施例2】実施例1と全く同様の反応をベンゼン中で
行ったところ収率72%であった。Example 2 When a reaction exactly the same as in Example 1 was carried out in benzene, the yield was 72%.
【0027】[0027]
【実施例3】実施例1と全く同様の反応をジクロルエタ
ン中で行ったところ収率72%であった。Example 3 A reaction exactly the same as in Example 1 was carried out in dichloroethane, and the yield was 72%.
【0028】[0028]
【実施例4】実施例1の3β−コレスタノールの代わり
にシクロヘキサノール8.8mgを用いて同様に行ったとこ
ろ、目的とするシクロヘキシルグルコピラノシドが54.2
mg(99%)得られた。Example 4 When 8.8 mg of cyclohexanol was used in place of the 3β-cholestanol of Example 1, the same procedure was carried out to find that the target cyclohexylglucopyranoside was 54.2%.
Obtained mg (99%).
【0029】[0029]
【実施例5】実施例4と同様に、メチル 2,3,4-トリ-O-
ベンジル-α-D-グルコピラノシド、メチル 2,3,6-トリ-
O-ベンジル-α-D-グルコピラノシド、1,6-アンヒドロ-
3,4-O-イソプロピリデン-β-D-ガラクトピラノース、1,
2:3,4-ジ-O-イソプロピリデン-α-D-ガラクトピラノー
スをそれぞれ1当量ずつ用い反応させた。その結果、収
率は62%, 34%, 40%, 66%であった。Example 5 Methyl 2,3,4-tri-O-as in Example 4
Benzyl-α-D-glucopyranoside, methyl 2,3,6-tri-
O-benzyl-α-D-glucopyranoside, 1,6-anhydro-
3,4-O-isopropylidene-β-D-galactopyranose, 1,
2: 3,4-Di-O-isopropylidene-α-D-galactopyranose was reacted using 1 equivalent each. As a result, the yields were 62%, 34%, 40%, 66%.
【0030】[0030]
【実施例6】フェニル 2,3,4,6−テトラ−O−
ベンジル−1−チオ−D−グルコピラノシド49.9mg(0.0
8mmol)、3β−コレスタノール30.7mg(0.08mmol)、過塩
素酸トリチル27.1mg(0.08mmol)をジクロルエタン2mlに
溶解し、これに0.1Mヨウ素/ジクロルエタン溶液0.75ml
を加えた。以下、実施例1と同様に処理したところ、3
β−コレスタニルグルコピラノシドが42.2mg(58%)得ら
れた。Example 6 Phenyl 2,3,4,6-tetra-O-
Benzyl-1-thio-D-glucopyranoside 49.9 mg (0.0
8 mmol), 3β-cholestanol 30.7 mg (0.08 mmol) and trityl perchlorate 27.1 mg (0.08 mmol) are dissolved in dichloroethane 2 ml, and 0.1M iodine / dichloroethane solution 0.75 ml
Was added. Thereafter, when the same treatment as in Example 1 was performed, 3
42.2 mg (58%) of β-cholestanyl glucopyranoside was obtained.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 // C07B 61/00 300 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Office reference number FI technical display location // C07B 61/00 300
Claims (2)
ル、芳香族アルコール、ステロイドアルコール、グリセ
ロール誘導体、糖誘導体、アミノ酸誘導体から選ばれる
アルコールとを、ヨウ素及び過塩素酸塩を共存させ、反
応させる事を特徴とするグリコシド系化合物の製造方
法。1. A reaction between a thioglycoside derivative and an alcohol selected from aliphatic alcohols, aromatic alcohols, steroid alcohols, glycerol derivatives, sugar derivatives and amino acid derivatives in the presence of iodine and perchlorate. A method for producing a characteristic glycoside compound.
る事を特徴とする請求項1記載の製造法。2. The production method according to claim 1, wherein trityl perchlorate is used as the perchlorate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6067706A JPH07252289A (en) | 1994-03-11 | 1994-03-11 | Production of glycoside compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6067706A JPH07252289A (en) | 1994-03-11 | 1994-03-11 | Production of glycoside compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07252289A true JPH07252289A (en) | 1995-10-03 |
Family
ID=13352679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6067706A Pending JPH07252289A (en) | 1994-03-11 | 1994-03-11 | Production of glycoside compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07252289A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6960654B2 (en) * | 2002-06-11 | 2005-11-01 | The Board Of Trustees Of The University Of Illinois | Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide |
-
1994
- 1994-03-11 JP JP6067706A patent/JPH07252289A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6960654B2 (en) * | 2002-06-11 | 2005-11-01 | The Board Of Trustees Of The University Of Illinois | Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barresi et al. | The synthesis of β-mannopyranosides by intramolecular aglycon delivery: scope and limitations of the existing methodology | |
| Kanie et al. | Glycosylation using methylthioglycosides of N-acetylneuraminic acid and dimethyl (methylthio) sulfonium triflate | |
| US4362720A (en) | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals | |
| US4308376A (en) | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals | |
| Javed et al. | Glycosyl 3-Phenyl-4-pentenoates as Versatile Glycosyl Donors: Reactivity and Their Application in One-Pot Oligosaccharide Assemblies | |
| JPH05247078A (en) | Sugar compound, sialic acid-containing sugar chain biosyhnthesis inhibitor, its production, and new intermediate | |
| KR900006213B1 (en) | N-glycolyl-neuramic acid-containing glycolipid and its preparation method | |
| Acher et al. | Ganglioside series. II. Further application of N-dichloroacetylhexosaminyl bromides to the synthesis of aminosaccharides | |
| NZ235578A (en) | 1,4-dideoxy-1,4-imino-d-arabinitol derivatives and their use as #a#-glucosidase inhibitors | |
| US6960654B2 (en) | Method of forming glycosidic bonds from thioglycosides using an N,N-dialkylsulfinamide | |
| Kum et al. | The synthesis of O-serine glycosides | |
| JPH07252289A (en) | Production of glycoside compound | |
| US5854408A (en) | Process for acylating the 1-position of saccharides | |
| JPH0631284B2 (en) | Method for producing glycoside from glycosyl fluoride | |
| Madsen et al. | n-Pentenyl glycosides in oligosaccharide synthesis | |
| KR920001690B1 (en) | Nitrosoures derivatives process for their preparation and medicaments containing them | |
| JPH03264595A (en) | Novel glycosylation method | |
| JP3553989B2 (en) | Novel glycosyl donor and method for producing glycoside compound using the same | |
| Rosenthal et al. | 9-[3-acetamido-3-C-(carboxymethyl)-3-deoxy-32, 2-lactone-α (andβ)-D-xylofuranosyl] adenine-analogs of the nucleoside moiety of the polyoxins | |
| CA1111417A (en) | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2- deoxyglycosides from glycals | |
| CA1111418A (en) | Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2- deoxyglycosides from glycals | |
| EP0647235B1 (en) | Process for steroidal peracyl glycosides | |
| Canas-Rodriguez et al. | Synthesis of 6-azido-and 6-amino-2, 3, 6-trideoxy-d-erythro-hexose | |
| JP4162739B2 (en) | Process for producing glycoside derivatives | |
| JPH08283285A (en) | Glycolipid having antiinflammatory action |